Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.
about
Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies.Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry.Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry.Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study.Determination of sunitinib and its active metabolite, N-desethyl sunitinib in mouse plasma and tissues by UPLC-MS/MS: assay development and application to pharmacokinetic and tissue distribution studies.Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors--review of assay methodologies and perspectives.Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate.Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain.Antineoplastic drugs and their analysis: a state of the art review.Therapeutic drug monitoring and tyrosine kinase inhibitors.Sunitinib LC-MS/MS Assay in Mouse Plasma and Brain Tissue: Application in CNS Distribution Studies.Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.Fast chromatography in the regulated bioanalytical environment: sub-2-µm versus fused-core particles.Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun study.Determination of sunitinib in human plasma using liquid chromatography coupled with mass spectrometry.Quantitation of sunitinib, an oral multitarget tyrosine kinase inhibitor, and its metabolite in urine samples by nonaqueous capillary electrophoresis time of flight mass spectrometry.
P2860
Q33581969-C6AAEAAA-573F-4577-ABD4-6D1FED55D419Q34132880-22EE359B-B579-4050-9B3B-1C4EF4A4C567Q34417423-35D591CC-C1A6-4F94-B2C8-5D652A818177Q34460026-79E3A79A-8AC7-448E-AE7C-A72CE8A86E56Q35039240-CB7B8E20-EC5F-4B37-832C-EF58B138B0BDQ35311474-7C73370E-3169-49CD-BCF9-F414D97DFF3EQ35450340-B270BAD9-6EF9-427A-B70A-707522F83ABCQ35626845-E9C60ABE-60C8-48D3-943D-D849B93E295EQ37331814-51B291B9-D372-4103-BBDE-CB4AAA2983A0Q39339684-B357106F-E017-4E69-A090-757F4B39E192Q41846251-0DC17F03-C8A4-43EB-A71C-CAD9E34B8662Q41853401-C44F2901-2B1D-4E6A-9568-74F5EC4BA863Q43841175-8BB96A9D-8D6F-4821-B15E-910A693AE333Q47853632-2C81696C-4167-4C0B-9248-25733C16783BQ47949741-01184F23-96CA-4AAC-B26F-84F035012BF5Q50465014-5F2B922E-16B1-4496-9F61-AF85E800296EQ53542598-3A36CE25-E5D9-4350-A4CF-6D7742E9A13B
P2860
Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Bioanalytical method for the q ...... -quadrupole mass spectrometry.
@ast
Bioanalytical method for the q ...... -quadrupole mass spectrometry.
@en
Bioanalytical method for the q ...... -quadrupole mass spectrometry.
@nl
type
label
Bioanalytical method for the q ...... -quadrupole mass spectrometry.
@ast
Bioanalytical method for the q ...... -quadrupole mass spectrometry.
@en
Bioanalytical method for the q ...... -quadrupole mass spectrometry.
@nl
prefLabel
Bioanalytical method for the q ...... -quadrupole mass spectrometry.
@ast
Bioanalytical method for the q ...... -quadrupole mass spectrometry.
@en
Bioanalytical method for the q ...... -quadrupole mass spectrometry.
@nl
P2093
P1476
Bioanalytical method for the q ...... -quadrupole mass spectrometry.
@en
P2093
Erik A C Wiemer
Mei-Ho Lam
Peter de Bruijn
Ron H J Mathijssen
Stefan Sleijfer
Walter J Loos
P304
P356
10.1016/J.JPBA.2009.10.020
P577
2009-10-31T00:00:00Z